Fosun Pharma (03933.HK) plans to discount approximately 7.93% to issue up to 156 million shares of placement shares, raising approximately HK$2.168 billion net.

Zhtng cijng APP xn, lintng zhyo (03933.HK) fb gnggo, 2025 nin 7 yu 18 r, bn gngs y dji pishu dil dngl "Pishu xiy", bn gngs yjng tngy wipn dji pishu dil, r dji pishu dil y tngy jishu wipn, y jn l csh mi ji n pishu gfn mi g 14.16 gngyun de pishu ji, rngu zudu 1.56 y g pishu gfn. Mi g pishu ji 14.16 gngyun b 2025 nin 7 yu 17 r shush ji mi g 15.38 gngyun zhku yu 7.93%. Zhtng cijng APP information, Federal Pharmaceuticals (03933.HK) announced that on July 18, 2025, the company entered into a "Placement Agreement" with the exclusive placement agent. The company has agreed to appoint the exclusive placement agent, and the exclusive placement agent has agreed to accept the appointment, to try to encourage buyers to subscribe for up to 156 million shares of placement shares at a placement price of HK$14.16 per share, a discount of about 7.93% from the closing price of HK$15.38 per share on July 17, 2025.